Guest guest Posted April 20, 2005 Report Share Posted April 20, 2005 We have a couple of patients on this list who are aware of this and know about it's details. I think at the moment they are just going into the second trial state. Perhaps someone can tell us. Also, Dr. Tuscano at UC in Sacramento has developed a MAB to treat CD12 as well, it is called Tuscanomab and is also going into it's second stage of trials etc. If there is anything good to learn I'm sure we will be one of the first groups to hear about it. Kurt Re: Brief talk with Dr. Kipps , UCSD is currently doing a trial using a CD23 MAB called Lumiliximab. Would be helpful if you could pick up some information on that new therapy. Best, Fred Hummel, 78, Arcata, CA; CLL/SLL dx 1.98; Fludara 2000; Rituxan, Fludara, Novantrone, & Decadron, 2002; Rituxan X 4 2004. Let's keep the list UNCLUTTERED!!! To do ANY HOUSEKEEPING business such as changing the way you get mail, please go to mygoups or mail me at scott_fs@.... ------------------------------------------------------------------------------ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.